Skip to main content
. Author manuscript; available in PMC: 2023 May 17.
Published in final edited form as: J Am Coll Surg. 2016 Feb 16;222(4):448–456. doi: 10.1016/j.jamcollsurg.2015.12.031

Table 2.

Oncologic and Treatment Data

Variable Surgery alone (n = 392) Adjuvant chemotherapy only (n = 291) Adjuvant chemoradiation (n = 447) p Value
Tumor size, cm, mean ± SD 2.9 ± 1.4 3.3 ± 2.1 3.1 ± 1.3 0.01
Tumor grade, n (%)* 0.61
 1 38 (11) 38 (13) 41 (9)
 2 219 (63) 175 (61) 276 (63)
 3 90 (26) 76 (26) 120 (28)
Tumor stage, n (%) 0.03
 I 57 (15) 21 (7) 63 (14)
 II 333 (85) 268 (92) 380 (85)
 III 2 (0.5) 2 (1) 4 (1)
Lymph nodes, positive, n (%) 166 (42) 203 (70) 261 (58) <0.001
Vein resection, yes, n (%) 44 (11) 50 (17) 70 (16) 0.062
Margin positive, yes, n (%) 64 (16) 61 (21) 124 (28) <0.001
Lymph nodes resected, median (IQR) 14 (8, 21) 18 (11, 27) 15 (9, 22) <0.001
Blood transfusion, yes, n (%) 114 (29) 75 (26) 126 (28) 0.623
Length of stay, d, median (IQR) 11 (8, 18) 9 (7, 13) 9 (7,12) <0.001
*

Grade 1, well differentiated; 2, moderately differentiated; 3, poorly differentiated.

p < 0.001, surgery alone vs adjuvant chemotherapy and adjuvant chemoradiation; p = 0.001, adjuvant chemotherapy vs adjuvant chemoradiation.

p = 0.12, surgery alone vs adjuvant chemotherapy; p < 0.001, surgery alone vs adjuvant chemoradiation; p = 0.03 adjuvant chemotherapy vs adjuvant chemoradiation. IQR, interquartile range.